This peer-to-peer networking session will answer your questions about decarbonization
The virtual summit takes place Wednesday, Sept. 27 from 1-3 p.m. ET. fnPrime members can register for free
It’s early days, however. There have been no human trials yet and no commercial partners.
The invention, AeroNabs, “may help reshape the course of the pandemic worldwide,” according to the inventors. They are in talks with potential manufacturers.
AeroNabs would be used once a day and administered by a shelf-stable inhaler or nasal spray.
The development of such a product could ease shortages. Hospital leaders across California, for instance, are describing growing PPE shortages.The California Hospital Association said the increase in COVID-19 hot spots, the lack of available testing and the length of time it's taking to get results are fueling the shortages, according to an ABC7 article.